Lanore, Aymeric https://orcid.org/0000-0002-8251-3410
Januel, Edouard
Bertille, Nathalie
Fabbri, Margherita
Mariani, Louise-Laure
Mangone, Graziella
Sambin, Sara
Menon, Poornima Jayadev
Tir, Melissa
Bereau, Matthieu
Meissner, Wassilios G.
Thiriez, Claire
Marques, Ana
Remy, Philippe
Dupont, Gwendoline
Moro, Elena
Defebvre, Luc
Houeto, Jean Luc
Thobois, Stéphane
Azulay, Jean-Philippe
Geny, Christian
Frismand, Solène
Damier, Philippe
Giordana, Caroline
Castelnovo, Giovanni
Ansquer, Solène
De Maindreville, Anne Doe
Drapier, Sophie
Maltête, David
Tranchant, Christine
Rascol, Olivier
Tubach, Florence
De Rycke, Yann
Corvol, Jean-Christophe
,
Funding for this research was provided by:
Investissements d’avenir (ANR-10- IAIHU-06)
Institut National de la Santé et de la Recherche Médicale
Article History
Accepted: 12 May 2025
First Online: 25 May 2025
Declarations
:
: The research leading to these results has received funding from the program ‘Investissements d’avenir’ ANR-10- IAIHU-06, French National Institute of Health and Medical Research (INSERM), Ministère des Solidarités et de la Santé – DGOS, Paris, France, and Agence nationale de la recherche, PIA 1 ‘INBS¡, F-CRIN, Paris, France. We are very grateful to the patients and family members who participated in the study.
: O.R. is an Editorial Board member of CNS Drugs. O.R. was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The authors report no other competing interests.
: The study received approval from an ethical committee in June 2020 (CPPIDF1-2020-ND58) and authorisation from the CNIL in February 2021 (DR-2021-039).
: All patients received information about the study and had the opportunity to exercise their right to refuse participation through the cohort transparency website in accordance with EU General Protection Data Regulation rules ().
: Not applicable.
: The supporting data for this study are not publicly available owing to their proprietary nature. However, they can be provided upon reasonable request to the corresponding author, subject to compliance with applicable regulations and institutional policies.
: Not applicable.
: A.L.: conceptualisation, data curation, formal analysis, methodology, visualisation, writing – original draft and writing – review and editing. E.J.: conceptualisation, methodology, statistical analysis support and critical review and editing. N.B.: database management, data curation and critical review. M.F., L.-L.M., G.M., S.S., P.J.M., M.T., M.B., W.G.M., C.T., A.M., P.R., G.D., E.M., L.D., J.L.H., S.T., J.-P.A., C.G., S.F., P.D., C.Gi., G.C, C.Ta., S.A., A.D.D.M., S.D., D.M. and C.Tra.: data acquisition and patient recruitment, critical review and editing. O.R., F.T., Y.D.R. and J.-C.C.: conceptualisation, supervision, methodology, statistical analysis support, critical review and editing.